Related Experiment Video
Updated: May 12, 2026

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Primary cardiac sarcoma after breast cancer
Joana Ramalho1, Sandra Nunes, Irene Marques
1Department of Medicine, Centro Hospitalar do Porto, Porto, Portugal. jasorblue@gmail.com
BMJ Case Reports
|April 24, 2013
Summary
This case study highlights a rare postradiation sarcoma in a breast cancer survivor. Despite prior treatments complicating management, the patient achieved a 3-year remission after surgical resection and chemoradiation therapy.
Area of Science:
- Oncology
- Cardiovascular Pathology
- Radiation Oncology
Background:
- Primary cardiac sarcomas are rare and associated with poor prognosis.
- Postradiation sarcoma is a known complication following cancer treatments like radiotherapy.
- Previous therapies for breast cancer can complicate subsequent treatment options.
Observation:
- A 56-year-old woman with a history of stage IIA breast cancer developed symptoms including fever, dyspnea, and leg edema.
- Echocardiography revealed a left atrial mass, later diagnosed as an intermediate-grade sarcoma.
- The patient had undergone mastectomy, chemotherapy, radiotherapy, and hormonotherapy for breast cancer, followed by treatment for pulmonary metastases.
Findings:
- Surgical resection of the cardiac sarcoma followed by chemoradiation therapy resulted in a 3-year disease-free survival.
- The patient remained alive with no tumor regrowth or metastasis at the 3-year follow-up.
- Histological analysis confirmed the tumor as a sarcoma of intermediate differentiation.
Implications:
- This case underscores the potential for developing secondary malignancies, such as cardiac sarcoma, after extensive cancer treatment.
- The management of postradiation sarcoma presents a therapeutic challenge, particularly when prior treatments limit further therapeutic options.
- Successful multimodal treatment involving surgery and chemoradiation offers a potential strategy for managing this rare complication.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
